[1]
Sharma, R. Herbal supplements or herbs in heart disease: History,
herbal foods, coronary heart disease, in bioactive food as dietary
interventions for cardiovascular disease. 2013, Elsevier. p. 29-61.
[2]
Abolhassani, M. Antiviral activity of borage (Echium amoenum). Arch. Med. Sci., 2010, 6(3), 366-369.
[3]
Asadi-Samani, M.; Bahmani, M.; Rafieian-Kopaei, M. The chemical composition, botanical characteristic and biological activities of Borago officinalis: A review. Asian Pac. J. Trop. Med., 2014, 7(S1), S22-S28.
[4]
Naghdi Badi, H.; Soroshzadeh, A.; Rezazadeh, S.H.; Sharifi, A.; Ghalavand, A.; Omidi, O. Review on borage (valuable medicinal plant and the richest plant source of gamma linolenic acid). J. Med. Plants, 2007, 6(24), 1-16.
[5]
Gómez-Estaca, J.; Giménez, P.; Montero, B.; Gómez-Guillén, M.C. Incorporation of antioxidant borage extract into edible films based on sole skin gelatin or a commercial fish gelatin. J. Food Eng., 2009, 92(1), 78-85.
[6]
Cheeke, P. Toxicity and metabolism of pyrrolizidine alkaloids. J. Anim. Sci., 1988, 66(9), 2343-2350.
[7]
Lozano-Baena, M.D.; Tasset, I.; Andres, M.; Angeles, A.M.; Antonio, H.B. Cancer prevention and health benefices of traditionally consumed Borago officinalis plants. Nutrients, 2016, 8(1), 1-16.
[8]
Kalhor, H.R.; Ashrafian, H. Identification of an aspidospermine derivative from borage extract as an anti-amyloid compound: A possible link between protein aggregation and antimalarial drugs. Phytochemistry, 2017, 140(Supplement. C), 134-140.
[9]
Gama, C.R.B.; Lasmar, R.; Gama, G.F.; Oliveira, L.; de Oliveira Naliato, E.C.; Ribeiro, M.G.; de Paoli, F.; de Souza da Fonseca, A.; Abreu, C.S.; Geller, M.; Santos, A. Clinical assessment of treatment outcomes following borago officinalis extract therapy in patients presenting with cyclical mastalgia. Int. J. Clin. Med., 2015, 6(6), 363-371.
[10]
Arginteanu, R. Method of reducing stress and circulatory heart
disease with freeze-dried borage petal extracts. 1998, Google
Patents.
[11]
Araghi, A.; Seifi, S.; Sayrafi, R.; Sadighara, P. Safety assessment of rice bran oil in a chicken embryo model. Avicenna J. Phytomed., 2016, 6(3), 351-356.
[12]
Gibson, X.A.; Shartava, A.; Mclntyre, J. The efficacy of reducing agents or antioxidants in blocking the formation of dense cells and irreversibly sickled cells in vitro. Blood, 1998, 91(11), 4373-4378.
[13]
Apak, R.; Guclu, K.; Ozyurek, M.; Celik, S. Mechanism of antioxidant capacity assays and the CUPRAC (cupric ion reducing antioxidant capacity) assay. Mikrochim. Acta, 2008, 160(4), 413-419.
[14]
Ma, Q. Transcriptional responses to oxidative stress: Pathological and toxicological implications. Pharmacol. Ther., 2010, 125(3), 376-393.
[15]
Giordano, F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest., 2005, 115(3), 500-508.
[16]
Sadighara, P.; Goudarzi, S.; Bahmani, M.; Asadi-Samani, M. Antioxidant activity and properties of walnut brown seed coat extract. J. Glob. Pharma Technol., 2016, 11(8), 26-30.
[17]
Sadighara, P.; Mohammadpour, I.; Jahanbakhsh, M.; Araghi, A.; Nazaktabar, A. The effect of stevia on the chicken embryo heart. Cardiovasc. Hematol. Disord. Drug Targets, 2016, 16(1), 38-40.